Drug
Dicloxacillin
Dicloxacillin is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
20%
Ph phase_4
1
20%
Ph phase_1
2
40%
Ph not_applicable
1
20%
Phase Distribution
2
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(3)
Detailed Status
Completed3
Recruiting2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 12 (40.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A1 (20.0%)
Trials by Status
completed360%
recruiting240%
Recent Activity
2 active trials
Showing 5 of 5
recruitingnot_applicable
Determinants of Warfarin Metabolism
NCT00162474
recruitingphase_4
Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis
NCT05398679
completedphase_1
The Effect of Dicloxacillin on Oral Absorption of Drugs
NCT05073627
completedphase_1
Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolism.
NCT02983890
completedphase_3
Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria
NCT00037050
Clinical Trials (5)
Showing 5 of 5 trials
NCT00162474Not Applicable
Determinants of Warfarin Metabolism
NCT05398679Phase 4
Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis
NCT05073627Phase 1
The Effect of Dicloxacillin on Oral Absorption of Drugs
NCT02983890Phase 1
Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolism.
NCT00037050Phase 3
Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5